Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis

被引：0
|
作者：
Martin Soubrier
Jinglan Pei
Frédérick Durand
Lars Gullestad
Ani John
机构：
[1] Centre Hospitalier Universitaire de Clermont-Ferrand,Department of Rheumatology
[2] Hôpital Gabriel-Montpied,Department of Cardiology, Faculty of Medicine, and Oslo University Hospital
[3] Genentech,undefined
[4] Inc,undefined
[5] LILLY FRANCE,undefined
[6] University of Oslo,undefined
来源：
Rheumatology and Therapy | 2017年 / 4卷
关键词：
Biologicals; Cardiovascular; Disease-modifying antirheumatic drugs (DMARDs); Low-density-lipoprotein cholesterol; Rheumatoid arthritis; Statins; Tocilizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：133 / 149
页数：16
相关论文
共 50 条
  • [31] INDUCTION AND PROGRESSION OF SUBCUTANEOUS NODULOSIS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB
    Talotta, R.
    Batticciotto, A.
    Ditto, M. C.
    Gerardi, M. C.
    Ventura, D.
    Puttin, P. Sarzi
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1194 - 1194
  • [32] INHIBITION OF LARGE JOINT DESTRUCTION IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOCILIZUMAB
    Hirano, Y.
    Hattori, K.
    Yamada, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1399 - 1400
  • [33] The clinical value of hematological markers in rheumatoid arthritis patients treated with tocilizumab
    Zhou, Li
    Xiao, Dong-Mei
    Qin, Wen
    Xie, Bin-Hua
    Wang, Ting-Hui
    Huang, Hua
    Zhao, Bao-Jing
    Han, Xi
    Sun, Qing-Qing
    Wu, Xiu-Di
    Cen, Han
    [J]. JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (05)
  • [34] Risk of Infections In Rheumatoid Arthritis Patients Treated with Tocilizumab-a Retrospective Data-Analysis
    Lang, Veronika
    Englbrecht, Matthias
    Rech, Juergen
    Manger, Bernhard
    Schett, Georg
    Zwerina, Jochen
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S470 - S470
  • [35] Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis
    Berardicurti, O.
    Ruscitti, P.
    Ursini, F.
    D'Andrea, S.
    Ciaffi, J.
    Meliconi, R.
    Iagnocco, A.
    Cipriani, P.
    Giacomelli, R.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (06) : 1247 - 1254
  • [36] Post-Hoc Analysis Of Serious Infection Events and Selected Clinical Factors In Rheumatoid Arthritis Patients Treated With Tofacitinib
    Gomez-Reino, J. J.
    Hazra, A.
    Fosser, C.
    Menon, S.
    Zwillich, S. H.
    Riese, R.
    Krishnaswami, S.
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S194 - S194
  • [37] PREDICTIVE FACTORS FOR REMISSION ACHIEVEMENT BY TOCILIZUMAB MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER INADEQUATE RESPONSE TO METHOTREXATE: A POST HOC ANALYSIS OF THE SURPRISE STUDY
    Kato, Masaru
    Kaneko, Yuko
    Tanaka, Yoshiya
    Inoo, Masayuki
    Kobayashi-Haraoka, Hitomi
    Amano, Koichi
    Miyata, Masayuki
    Murakawa, Yohko
    Yasuoka, Hidekata
    Hirata, Shintaro
    Nagasawa, Hayato
    Tanaka, Eiichi
    Miyasaka, Nobuyuki
    Yamanaka, Hisashi
    Yamamoto, Kazuhiko
    Yokota, Isao
    Atsumi, Tatsuya
    Takeuchi, Tsutomu
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 714 - 715
  • [38] Female reproductive status and exogenous sex hormone use in rheumatoid arthritis patients treated with tocilizumab and csDMARDs
    Daraghmeh, Dala N.
    Hopkins, Ashley M.
    King, Catherine
    Abuhelwa, Ahmad Y.
    Wechalekar, Mihir D.
    Proudman, Susanna M.
    Sorich, Michael J.
    Wiese, Michael D.
    [J]. RHEUMATOLOGY, 2023, 62 (02) : 583 - 595
  • [39] IMMUNOGENICITY OF CERTOLIZUMAB PEGOL WITHOUT CONCOMITANT METHOTREXATE AND CLINICAL RESPONSE IN RHEUMATOID ARTHRITIS PATIENTS: POST-HOC ANALYSIS OF THE HIKARI STUDY
    Takeuchi, T.
    Yamamoto, K.
    Yamanaka, H.
    Ishiguro, N.
    Tanaka, Y.
    Eguchi, K.
    Watanabe, A.
    Origasa, H.
    Wada, Y.
    Shoji, T.
    Miyasaka, N.
    Koike, T.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 440 - 440
  • [40] Use of Statins and the Risk of Rheumatoid Arthritis
    de Jong, H.
    Klungel, O.
    van Dijk, L.
    Vandebriel, R.
    Leufkens, H.
    Tervaert, J. W. Cohen
    van Loveren, H.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S126 - S126
12345